Immunotherapy and Liver Transplantation The Future or the Failure?

被引：4

作者：

Tabrizian, Parissa ^{[1
]}

Yu, Allen ^{[1
]}

Debnath, Neha ^{[1
]}

Myers, Bryan ^{[1
]}

Marron, Thomas ^{[1
]}

机构：

[1] Icahn Sch Med Mt Sinai, Recanati Miller Transplantat Inst, Liver Transplant & Hepatobiliary Surg, One Gustave L Levy, New York, NY 10029 USA

来源：

SURGICAL CLINICS OF NORTH AMERICA | 2024年 / 104卷 / 01期

关键词：

Liver transplantation; Hepatocellular carcinoma; Immunotherapy; Rejection; Outcomes; RESECTABLE HEPATOCELLULAR-CARCINOMA; ATEZOLIZUMAB PLUS BEVACIZUMAB; NEOADJUVANT THERAPY; OPEN-LABEL; PHASE-III; TRIAL; RISK; PEMBROLIZUMAB; NIVOLUMAB; ADJUVANT;

D O I：

10.1016/j.suc.2023.07.009

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

center dot The increasing demand for liver transplantation (LT) for hepatocellular carcinoma (HCC) has led to the continued efforts to expand LT indications.center dot Immunotherapy has revolutionized the treatment of advanced HCC over the past few years.center dot HCC and other solid tumors exploit evolutionary conserved inhibitory immune checkpoints to evade antitumor immune response by upregulating cognate ligands or receptors capable of inhibiting antitumor immunity.

引用

页码：163 / 182

页数：20

共 50 条

[1] Immunotherapy for Hepatocellular Carcinoma in the Setting of Liver Transplantation: A Review
Lominadze, Zurabi
Hill, Kareen
Shaik, Mohammed Rifat
Canakis, Justin P.
Bourmaf, Mohammad
Adams-Mardi, Cyrus
Abutaleb, Ameer
Mishra, Lopa
Shetty, Kirti
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
[2] Immunotherapy in liver transplantation for hepatocellular carcinoma: Pros and cons
Luo, Yi
Teng, Fei
Fu, Hong
Ding, Guo-Shan
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022, 14 (01) : 163 - 180
[3] Liver resection and transplantation in the era of checkpoint inhibitors
Tabrizian, Parissa
Marino, Rebecca
Chow, Pierce K. H.
JHEP REPORTS, 2024, 6 (11)
[4] Mechanism, Potential, and Concerns of Immunotherapy for Hepatocellular Carcinoma and Liver Transplantation
Sensi, Bruno
Angelico, Roberta
Toti, Luca
Conte, Luigi
Coppola, Alessandro
Tisone, Giuseppe
Manzia, Tommaso Maria
CURRENT MOLECULAR PHARMACOLOGY, 2024, 17
[5] Immunotherapy and Liver Transplantation: A Narrative Review of Basic and Clinical Data
Wassmer, Charles-Henri
El Hajji, Sofia
Papazarkadas, Xenofon
Compagnon, Philippe
Tabrizian, Parissa
Lacotte, Stephanie
Toso, Christian
CANCERS, 2023, 15 (18)
[6] Immunotherapy for transplantation of hepatocellular carcinoma: the next frontier in adjunctive therapy
Tabrizian, Parissa
Zeitlhoefler, Marcus
Hassan, Ahmed Talaat
Marino, Rebecca
CURRENT OPINION IN ORGAN TRANSPLANTATION, 2024, 29 (02) : 144 - 154
[7] Immunotherapy for hepatocellular carcinoma: The next evolution in expanding access to liver transplantation
Li, Michael
Bhoori, Sherrie
Mehta, Neil
Mazzaferro, Vincenzo
JOURNAL OF HEPATOLOGY, 2024, 81 (04) : 743 - 755
[8] Harnessing the Power of Immunotherapy in Liver Transplantation for HCC
Alhaqqan, Dalal
Khiew, Yii Chun
Dadashzadeh, Maryam
He, Aiwu Ruth
Thomas, Arul
Rangnekar, Amol
CURRENT TRANSPLANTATION REPORTS, 2024, 11 (03) : 131 - 139
[9] Advances and effectiveness of the immunotherapy after liver transplantation
Vulasala, Sai Swarupa R.
Onteddu, Nirmal K.
Kumar, Sindhu P.
Lall, Chandana
Bhosale, Priya
Virarkar, Mayur K.
WORLD JOURNAL OF GASTROINTESTINAL SURGERY, 2022, 14 (06): : 629 - 631
[10] Role of immunotherapy in the management of hepatocellular carcinoma: current standards and future directions
Weinmann, A.
Galle, P. R.
CURRENT ONCOLOGY, 2020, 27 : S152 - S164

← 1 2 3 4 5 →